DKFZ MRinRT 2021 – Virtual

18-21 April 2021

Germany


The development of a fully adaptive, AI-powered treatment planning software is urgently needed. We are proud to be introducing our new era of MR-based proudcts that will pave the way towards this vision of radiation therapy on the fly for more efficient, safe and precise treatment for cancer patients.

Professor Nikos Paragyios
CEO & CTO at TheraPanaceaProfessor of Mathematics – University of Paris-Saclay
Editor in Chief, Computer Vision at Elsevier

WEBINAR

AI: the missing link in MR-guided radiotherapy?

TheraPanacea is thrilled to engage a fascinating conversation with experts in Medical Physics, Radio-oncology and AI, come & listen to their insights.

Prof. Daniela Thorwarth

University Hospital Tübingen,
Germany

Prof. Enis Özyar

Acibadem MAA University, Maslak Hospital,
Istanbul

Prof. Nikos Paragyios

Founder & CEO
TheraPanacea

Thais ROQUE, PhD

Research & Clinical Partnerships Manager
TheraPanacea


What do KOLs think of ART-Plan™?

ART-Plan™ has experienced a very high level of acceptance in the different teams of our department in the University Hospital for Radiation Oncology Tübingen, Germany, as it saves a lot of valuable time that can be used for complex treatment planning tasks and interdisciplinary discussions.

Professor Daniela Thorwarth
Head of Biomedical Physics Research University of Tübingen,
Germany

Symposium

Get smarter – AI in Radiation Oncology

Andreas Schulte

Director International Business Development,
TheraPanacea

Watch Replay